Corteva, Inc. (CTVA) reported $2.62 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 12.6%. EPS of -$0.23 for the same period compares to -$0.49 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $2.49 billion, representing a surprise of +5.2%. The company delivered an EPS surprise of +53.06%, with the consensus EPS estimate being -$0.49.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Seed: $917 million versus $765.33 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +32.7% change.
- Revenue- Crop Protection: $1.7 billion versus the four-analyst average estimate of $1.76 billion. The reported number represents a year-over-year change of +4%.
- Revenue- Crop Protection- Other: $110 million versus the two-analyst average estimate of $149.2 million. The reported number represents a year-over-year change of -55.3%.
- Revenue- Seed- Other: $38 million versus the two-analyst average estimate of $75.13 million. The reported number represents a year-over-year change of -50.7%.
- Revenue- Crop Protection- Herbicides: $813 million versus $800.99 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +10.5% change.
- Revenue- Crop Protection- Insecticides: $409 million versus $447.85 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.4% change.
- Revenue- Crop Protection- Fungicides: $222 million versus the two-analyst average estimate of $272.74 million. The reported number represents a year-over-year change of +2.8%.
- Revenue- Seed- Soybean: $152 million versus the two-analyst average estimate of $174.91 million. The reported number represents a year-over-year change of -7.3%.
- Revenue- Seed- Corn: $586 million compared to the $411.07 million average estimate based on two analysts. The reported number represents a change of +86% year over year.
- Revenue- Seed- Other oilseeds: $141 million versus the two-analyst average estimate of $122.51 million. The reported number represents a year-over-year change of +4.4%.
- Operating EBITDA- Seed: $-193 million compared to the $-310.39 million average estimate based on four analysts.
- Operating EBITDA- Corporate: $-37 million versus the four-analyst average estimate of $-29.64 million.
View all Key Company Metrics for Corteva, Inc. here>>>
Shares of Corteva, Inc. have returned -3.5% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Corteva, Inc. (CTVA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
